Patents by Inventor E. Lucile White

E. Lucile White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10532999
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: January 14, 2020
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, SOUTHERN RESEARCH INSTITUTE
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Publication number: 20190270730
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Application
    Filed: October 1, 2018
    Publication date: September 5, 2019
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Patent number: 10087168
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: October 2, 2018
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC., SOUTHERN RESEARCH INSTITUTE
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Patent number: 9688653
    Abstract: This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: June 27, 2017
    Assignees: Duke University, University of Kansas, Southern Research Institute
    Inventors: Patrick C. Seed, Carlos C. Goller, Steven Rogers, Brooks Maki, Frank Schoenen, James Noah, E. Lucile White
  • Publication number: 20170166557
    Abstract: The present technology relates to compounds and compositions of Formulas and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Application
    Filed: February 27, 2017
    Publication date: June 15, 2017
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Patent number: 9593095
    Abstract: This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: March 14, 2017
    Assignees: Duke University, University of Kansas, Southern Research Institute
    Inventors: Patrick C. Seed, Carlos C. Goller, Steven Rogers, Brooks Maki, Frank Schoenen, James Noah, E. Lucile White
  • Patent number: 9580393
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: February 28, 2017
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC., SOUTHERN RESEARCH INSTITUTE
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Publication number: 20150329499
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Application
    Filed: December 13, 2013
    Publication date: November 19, 2015
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Patent number: 7718651
    Abstract: The invention relates to inhibitors of FtsZ polymerization and uses thereof.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: May 18, 2010
    Assignee: Southern Research Institute
    Inventors: E. Lucile White, Robert C. Reynolds, William J. Suling
  • Publication number: 20100113429
    Abstract: The invention relates to inhibitors of FtsZ polymerization and uses thereof.
    Type: Application
    Filed: December 31, 2009
    Publication date: May 6, 2010
    Inventors: E. Lucile White, Robert C. Reynolds, William J. Suling